Skip to main content
ZheJiang Tailin Bioengineering Co.,Ltd logo

ZheJiang Tailin Bioengineering Co.,Ltd — Investor Relations & Filings

Ticker · 300813 ISIN · CNE100003S89 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 990 across all filing types
Latest filing 2025-08-28 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 300813

About ZheJiang Tailin Bioengineering Co.,Ltd

https://www.tailingood.com

ZheJiang Tailin Bioengineering Co.,Ltd. specializes in the research, development, and manufacturing of high-tech equipment for life sciences and pharmaceutical engineering. The company provides integrated solutions for microbial control, sterility testing, and aseptic processing. Its core product portfolio includes sterility test canisters and pumps, microbial limit testing systems, and hydrogen peroxide vapor (VHP) decontamination units. Tailin also develops advanced isolator technology for containment and aseptic applications, alongside analytical instruments such as Total Organic Carbon (TOC) analyzers and filter integrity testers. These products are designed to meet international regulatory standards, including GMP, USP, and EP. The company serves sectors such as biopharmaceuticals, medical devices, and laboratory research, focusing on product safety and quality through specialized engineering and microbial detection technologies.

Recent filings

Filing Released Lang Actions
股东会网络投票实施细则
Governance Information Classification · 95% confidence The document is titled as the "Implementation Rules for Online Voting at the Shareholders' Meeting" of Zhejiang Tailin Biotechnology Co., Ltd. It details the procedures, rules, and technical systems for shareholders to vote online during shareholder meetings. It references relevant laws and stock exchange rules, but it is not a report of financial results, management discussion, or an announcement of voting results. It is a procedural and governance document related to shareholder meeting voting mechanisms. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules and governance practices.
2025-08-28 Chinese
公司章程
Governance Information Classification · 100% confidence The document is titled as the Articles of Association (章程) of Zhejiang Tailin Bioengineering Co., Ltd. It contains detailed provisions about the company's governance structure, shareholder rights, board of directors, management, share issuance, capital changes, and other corporate governance matters. It references relevant laws and regulations such as the Company Law of the People's Republic of China, Securities Law, and listing rules. The content is a comprehensive governance document that sets out the internal rules and regulations of the company rather than a financial report, announcement, or meeting material. Therefore, it fits the category of Governance Information (CGR). The document length is substantial and contains detailed governance provisions, not a brief announcement or a report publication notice.
2025-08-28 Chinese
董事会秘书工作细则
Governance Information Classification · 95% confidence The document is titled '董事会秘书工作细则' which translates to 'Board Secretary Work Rules'. It outlines the duties, qualifications, appointment, and legal responsibilities of the company's board secretary. The content focuses on governance practices, internal rules, and compliance with relevant laws and stock exchange regulations. There is no financial data, no report of financial results, no announcement of voting results, no legal proceeding updates, and no mention of any specific report filings. The document is a governance-related internal policy document rather than a financial report or announcement. Therefore, the most appropriate classification is Governance Information (CGR). The document length is 2538 characters, which is consistent with a detailed governance policy document rather than a brief announcement or a full annual report.
2025-08-28 Chinese
子公司管理制度
Governance Information Classification · 95% confidence The document is titled '子公司管理制度' which translates to 'Subsidiary Management System' and contains detailed internal management rules and governance structures for subsidiaries of Zhejiang Tailin Biotechnology Co., Ltd. It outlines corporate governance, strategic management, financial and audit management, human resources, and other internal control policies. There is no indication that this is a financial report, audit report, earnings release, or any regulatory filing. It is a governance-related document detailing internal rules and management practices. Therefore, it fits best under Governance Information (CGR). The document length and content confirm it is the actual governance report, not an announcement or summary.
2025-08-28 Chinese
信息披露管理制度
Governance Information Classification · 95% confidence The document is a detailed information disclosure management system of Zhejiang Tailin Biotechnology Co., Ltd., outlining principles, rules, and procedures for information disclosure, including definitions of periodic reports (annual, interim, quarterly), temporary reports, disclosure of transactions, board and shareholder meeting procedures, and related regulatory compliance. It references Chinese securities laws, Shenzhen Stock Exchange rules, and detailed requirements for disclosures, audits, and approvals. The content is regulatory and governance-focused, describing how the company manages and discloses information to investors and regulators. It is not an actual financial report, earnings release, call transcript, or announcement of voting results. It is a governance and compliance document detailing internal rules and disclosure practices. Therefore, the most appropriate classification is Governance Information (CGR).
2025-08-28 Chinese
募集资金管理制度
Governance Information Classification · 95% confidence The document is a detailed internal policy document titled '募集资金管理制度' (Fundraising Capital Management System) for Zhejiang Tailin Biotechnology Co., Ltd. It outlines the rules, procedures, and controls for managing and using funds raised through stock issuance. The content includes regulatory references, internal control measures, usage restrictions, supervisory responsibilities, and reporting requirements related to fundraising capital. It is not a financial report, earnings release, or announcement but rather a governance and compliance document detailing internal rules and procedures for capital management. Therefore, it fits best under Governance Information (CGR). The document length (6909 characters) and detailed procedural content support this classification with high confidence.
2025-08-28 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.